61350-00-3,MFCD00548412
Catalog No.:AA00ECGO

61350-00-3 | VU 0364770

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
99+%
in stock  
$10.00   $7.00
- +
5mg
99+%
in stock  
$22.00   $16.00
- +
10mg
99+%
in stock  
$32.00   $23.00
- +
25mg
99+%
in stock  
$59.00   $42.00
- +
50mg
99+%
in stock  
$87.00   $61.00
- +
100mg
99+%
in stock  
$134.00   $94.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00ECGO
Chemical Name:
VU 0364770
CAS Number:
61350-00-3
Molecular Formula:
C12H9ClN2O
Molecular Weight:
232.6657
MDL Number:
MFCD00548412
SMILES:
Clc1cccc(c1)NC(=O)c1ccccn1
Properties
Computed Properties
 
Complexity:
247  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.6  

Literature

Title: Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.

Journal: Neuropharmacology 20150801

Title: The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.

Journal: The Journal of pharmacology and experimental therapeutics 20120201

Title: Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).

Journal: Journal of medicinal chemistry 20090723

Title: Jones CK, et al. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. J Pharmacol Exp Ther. 2012 Feb;340(2):404-21.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:61350-00-3 Molecular Formula|61350-00-3 MDL|61350-00-3 SMILES|61350-00-3 VU 0364770
Catalog No.: AA00ECGO
61350-00-3,MFCD00548412
61350-00-3 | VU 0364770
Pack Size: 1mg
Purity: 99+%
in stock
$10.00 $7.00
Pack Size: 5mg
Purity: 99+%
in stock
$22.00 $16.00
Pack Size: 10mg
Purity: 99+%
in stock
$32.00 $23.00
Pack Size: 25mg
Purity: 99+%
in stock
$59.00 $42.00
Pack Size: 50mg
Purity: 99+%
in stock
$87.00 $61.00
Pack Size: 100mg
Purity: 99+%
in stock
$134.00 $94.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00ECGO
Chemical Name: VU 0364770
CAS Number: 61350-00-3
Molecular Formula: C12H9ClN2O
Molecular Weight: 232.6657
MDL Number: MFCD00548412
SMILES: Clc1cccc(c1)NC(=O)c1ccccn1
Properties
Complexity: 247  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 16  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.6  
Literature fold

Title: Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.

Journal: Neuropharmacology20150801

Title: The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.

Journal: The Journal of pharmacology and experimental therapeutics20120201

Title: Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).

Journal: Journal of medicinal chemistry20090723

Title: Jones CK, et al. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. J Pharmacol Exp Ther. 2012 Feb;340(2):404-21.

Building Blocks More >
641569-97-3
641569-97-3
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester
AA00ECMK | MFCD11100712
619-22-7
619-22-7
3-(Dimethylamino)benzaldehyde
AA00ECT1 | MFCD05148649
574-42-5
574-42-5
(Oxybis(methanetriyl))tetrabenzene
AA00ECYS | MFCD00030056
63326-75-0
63326-75-0
Thieno[2,3-c]pyridin-3-amine
AA00ED7J | MFCD09998716
6401-63-4
6401-63-4
Z-Leu-phe-oh
AA00EDFO | MFCD00191122
594810-90-9
594810-90-9
2-Bromo-1-(2-bromo-4-fluorophenyl)ethanone
AA00EDPM | MFCD11847026
590376-88-8
590376-88-8
5-(4-Ethyl-5-methylthien-3-yl)-4-methyl-4h-1,2,4-triazole-3-thiol
AA00EDTO | MFCD03423436
61147-43-1
61147-43-1
3-(Benzyloxy)benzonitrile
AA00EDXB | MFCD04038812
5934-56-5
5934-56-5
(2R,3S,4R,5S)-2,3,4,5,6-Pentahydroxyhexanal
AA00EE1Q | MFCD00069825
63035-27-8
63035-27-8
(1,4-Diazepan-1-yl)(tetrahydrofuran-2-yl)methanone
AA00EE53 | MFCD08691453
Submit
© 2017 AA BLOCKS, INC. All rights reserved.